South32 Limited (ASX:S32)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	13,151	16,516	17,048	18,190	13,611	9,762
Market Cap Growth	-0.04%	-3.12%	-6.28%	33.64%	39.43%	-38.29%
Enterprise Value	13,248	18,115	17,485	16,841	13,242	9,366
Last Close Price	2.93	3.55	3.59	3.48	2.47	1.70
PE Ratio	78.26	-	-	4.70	-	-
Forward PE	11.66	10.95	7.98	4.37	11.68	18.66
PS Ratio	1.31	1.97	1.97	1.34	1.83	1.31
PB Ratio	0.89	1.23	1.21	1.16	1.14	0.71
P/TBV Ratio	0.91	1.26	1.24	1.18	1.16	0.72
P/FCF Ratio	22.42	5509.61	37.45	5.06	12.52	10.73
P/OCF Ratio	5.96	9.85	9.53	4.08	7.26	4.94
PEG Ratio	-	0.08	-	0.17	0.26	1.23
EV/Sales Ratio	1.32	2.16	2.02	1.24	1.78	1.26
EV/EBITDA Ratio	7.76	19.62	14.71	2.86	6.77	6.94
EV/EBIT Ratio	14.26	223.82	41.71	3.38	12.84	26.95
EV/FCF Ratio	22.59	6043.04	38.41	4.68	12.18	10.30
Debt / Equity Ratio	0.18	0.18	0.19	0.17	0.14	0.11
Debt / EBITDA Ratio	1.60	2.54	2.20	0.45	0.82	1.09
Debt / FCF Ratio	4.54	783.00	5.75	0.74	1.48	1.62
Asset Turnover	0.44	0.39	0.37	0.63	0.41	0.36
Inventory Turnover	2.85	2.93	3.06	3.76	3.05	2.71
Quick Ratio	1.89	0.80	1.27	1.69	1.47	1.46
Current Ratio	2.83	2.39	2.08	2.24	2.00	2.10
Return on Equity (ROE)	-2.62%	-6.98%	-6.13%	27.05%	1.53%	1.60%
Return on Assets (ROA)	2.42%	0.23%	1.13%	14.50%	3.58%	1.05%
Return on Capital (ROIC)	3.13%	0.31%	1.47%	18.83%	4.66%	1.39%
Return on Capital Employed (ROCE)	4.30%	0.40%	2.10%	23.80%	6.60%	1.90%
Earnings Yield	1.28%	-1.84%	-1.52%	21.30%	-1.91%	-0.96%
FCF Yield	4.46%	0.02%	2.67%	19.77%	7.99%	9.32%
Dividend Yield	3.44%	1.48%	3.39%	9.46%	2.65%	1.79%
Payout Ratio	151.92%	-	-	21.24%	-	-
Buyback Yield / Dilution	0.71%	1.16%	2.29%	2.21%	2.43%	3.94%
Total Shareholder Return	4.15%	2.64%	5.68%	11.68%	5.07%	5.73%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.